Detalles de la búsqueda
1.
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
J Clin Oncol
; 23(28): 6865-72, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16192578
2.
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
J Natl Cancer Inst
; 95(5): 362-72, 2003 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-12618501
3.
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
J Clin Oncol
; 21(16): 3025-34, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12837810
4.
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Lung Cancer
; 76(3): 457-64, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22297086
5.
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.
J Clin Oncol
; 25(29): 4663-9, 2007 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17925563
6.
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
Lancet Oncol
; 6(9): 669-77, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16129367
7.
Supportive care in patients with advanced non-small-cell lung cancer.
Br J Cancer
; 89(6): 1013-21, 2003 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12966418
Resultados
1 -
7
de 7
1
Próxima >
>>